DSM is introducing application-specific versions of its Preventase enzyme; meanwhile, Novozymes is launching Acrylaway in Australia and New Zealand after having received regulatory approval.
Giant German supplier BASF has increased the price of propionic acid for the second time since May as energy and raw materials costs continue to spiral.
The enzymes market is experiencing some increased popularity among manufacturers because of their desired functionality and ability to help save costs, says a new report.
Acrylaway, the acrylamide-reducing enzyme from Novozymes, has received approval in a slate of countries worldwide and is now being applied across broad range of bakery and snack products.
The acrylamide-reducing enzyme Preventase has been granted approval for use in Switzerland, marking a new step down the road towards industry-wide adoption for biscuits and other baked goods.
Denmark's Chr Hansen is set to launch a second-generation Fermentation Produced Chymosin (FPC) for the cheese market, promising cost-efficiency and better process control.
Efforts to reduce acrylamide remain a priority as the European Food Safety Authority (EFSA) concludes risk assessments regarding the carcinogen will stay the same.
Cognis has announced an increase in the price of natural source vitamin E in North America for the first time in more than six years as input costs spiral.
Germany-based Gene Bridges has licensed its Red/ET Recombineering technology to Novozymes for genetically engineering recombinant micro-organisms for use in industrial applications.
Puratos and Novozymes have teamed up to develop a bio-solution to help industrial cake manufacturers increase the softness and freshness of their products, the companies have announced.
Denmark's Novozymes has signed an exclusive worldwide licensing agreement with CSL Behring for albufuse, a proprietary albumin fusion technology that can extend the circulatory half-life of therapeutic proteins through genetic fusion to recombinant human albumin.